Gary C. Yee - Concepedia

Author

Gary C. Yee

Also Known As

Anderson, Kenneth, G C Yee, Gary C Yee, Gary C. Yee, Gary Yee, Gary c. Yee, Michael S Maddux, Robert L. Talbert, Yee, Gary

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of Nebraska Medical Center St. Jude Children's Research Hospital University of Washington University of Michigan

About

Gary C. Yee is an author at Fred Hutch Cancer Center specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.3K
2	Health Sciences	4	4	332
3	Public Health	4	4	552
4	Education	3	3	81
5	Humanities	1	1	32

Gary C. Yee

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia Rainer Storb, H. Joachim Deeg, John Whitehead, New England Journal of Medicine	1986	1.4K
American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer Bruce E. Hillner, James N. Ingle, Rowan T. Chlebowski, Journal of Clinical Oncology	2003	970
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma James R. Berenson, Bruce E. Hillner, Robert A. Kyle, Journal of Clinical Oncology	2002	540
American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma Robert A. Kyle, Gary C. Yee, Mark R. Somerfield, Journal of Clinical Oncology	2007	409
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer Bruce E. Hillner, James N. Ingle, James R. Berenson, Journal of Clinical Oncology	2000	382
Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis John R. Wingard, Paul Kubilis, Lily Lee, Clinical Infectious Diseases	1999	360
American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer Catherine Van Poznak, Sarah Temin, Gary C. Yee, Journal of Clinical Oncology	2011	342
Venous Thromboembolic Disease Michael B. Streiff, Paula Bockenstedt, Spero R. Cataland, Journal of the National Comprehensive Cancer Network Risk EvaluationPathologyPharmacotherapyThrombosisVenous Thrombosis	2011	234
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015 Michael B. Streiff, Bjorn Holmstrom, Aneel A. Ashrani, Journal of the National Comprehensive Cancer Network Version 1.2015PathologyEffective ProphylaxisPharmacotherapyThrombosis	2015	216
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update Catherine Van Poznak, Mark R. Somerfield, William E. Barlow, Journal of Clinical Oncology Breast OncologyPain MedicinePharmacotherapyOrthopaedic SurgeryBone Disease	2017	174

Page 1